Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Los Angeles, California

Phase 1 cancer trials in Los Angeles, CA

156 Phase 1 cancer studies are recruiting participants at sites in Los Angeles as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Los Angeles at a glance

  • 156 studies are recruiting at a site in Los Angeles.
  • By phase: Early Phase 1 (5), Phase 1 (63), Phase 1/2 (88).
  • By sponsor: industry (129), university, hospital or other (24), government (3).
  • By research area: Breast Cancer (55), Lung Cancer (49), Lymphoma (22), Prostate Cancer (13), Pancreatic Cancer (10), Melanoma (7).
  • Most recent update to one of these records: November 17, 2026.

Breast cancer studies recruiting in Los Angeles

Basic details from each study's public record (the 30 most recently updated of 156). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

    • Phase 1
    • Ages 18 and older
    • Female participants
    Sponsor
    Totus Medicines
    Study site
    University of Southern California Cancer Center
    Registry record
    NCT05683418 · updated
  2. A Phase 1/2 Study of IAM1363 in HER2 Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Iambic Therapeutics, Inc
    Study site
    USC Norris Comprehensive Cancer Center
    Registry record
    NCT06253871 · updated
  3. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Study sites
    Ellison Medical Institute · University of California Los Angeles · Valkyrie Clinical Trials
    Registry record
    NCT06324357 · updated
  4. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    START Los Angeles
    Registry record
    NCT07488676 · updated
  5. Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

    • Phase 1
    • Ages 12 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study sites
    Keck Medicine of USC Koreatown · Los Angeles General Medical Center · USC / Norris Comprehensive Cancer Center
    Registry record
    NCT05372640 · updated
  6. Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer

    • Phase 1
    • Ages 18 and older
    • Female participants
    Sponsor
    Immunomic Therapeutics, Inc.
    Study site
    The Angeles Clinic and Research Institute (TACRI)
    Registry record
    NCT07652242 · updated
  7. A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    UCLA Health 200 Medical Plaza
    Registry record
    NCT03424005 · updated
  8. A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 19 and older
    • All sexes
    Sponsor
    NiKang Therapeutics, Inc.
    Study site
    University of California - Los Angeles
    Registry record
    NCT06586957 · updated
  9. Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Genmab
    Study site
    University of California Los Angeles Medical Center
    Registry record
    NCT05579366 · updated
  10. A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    UCLA Department of Medicine-Hematology/Oncology
    Registry record
    NCT06465069 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Los Angeles, CA on ClinicalTrials.gov.

Lung cancer studies recruiting in Los Angeles

  1. Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Institut de Recherches Internationales Servier
    Study sites
    The Angeles clinic - A cedars SINAI AFFILIATE · USC Norris Comprehensive Cancer Center
    Registry record
    NCT05786924 · updated
  2. A Study of VET3-TGI in Patients With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    KaliVir Immunotherapeutics
    Study site
    USC/Norris Comprehensive Cancer Center
    Registry record
    NCT06444815 · updated
  3. A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    EpiBiologics
    Study site
    Site 105 - START Los Angeles
    Registry record
    NCT07462377 · updated
  4. A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BioNTech SE
    Study site
    UCLA Hematology Oncology - Main Site
    Registry record
    NCT07111520 · updated
  5. Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Study site
    Valkyrie Clinical Trials
    Registry record
    NCT04886804 · updated
  6. Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    SystImmune Inc.
    Study site
    Valkyrie Clinical Trials
    Registry record
    NCT07080242 · updated
  7. A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kestrel Therapeutics, Inc.
    Study site
    Cedars-Sinai Medical Center
    Registry record
    NCT07458347 · updated
  8. A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    Cedars-Sinai Medical Center
    Registry record
    NCT07020221 · updated
  9. Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Inhibrx Biosciences, Inc
    Study sites
    California Research Institute · Valkyrie Clinical Trials
    Registry record
    NCT04198766 · updated
  10. A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Administrative Address: UCLA Hematology/Oncology · Ronald Reagan UCLA Medical Center
    Registry record
    NCT07090499 · updated
  11. Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma

    • Early Phase 1
    • Ages 22 and older
    • All sexes
    Sponsor
    Jonsson Comprehensive Cancer Center
    Study site
    UCLA / Jonsson Comprehensive Cancer Center
    Registry record
    NCT07235280 · updated
  12. A 2-part Phase 1/2 Open-label Trial on ODM-212

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Orion Corporation, Orion Pharma
    Study site
    Valkyrie Clinical Trials
    Registry record
    NCT07563738 · updated
  13. A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BlossomHill Therapeutics
    Study site
    Cedars-Sinai Cancer at Cedars Sinai Medical Center
    Registry record
    NCT06706076 · updated
  14. Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    USC Norris Comprehensive Cancer Center
    Registry record
    NCT07397338 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Los Angeles, CA on ClinicalTrials.gov.

Prostate cancer studies recruiting in Los Angeles

  1. First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

    • Phase 1/2
    • Ages 18 and older
    • Male participants
    Sponsor
    GlaxoSmithKline
    Study site
    GSK Investigational Site
    Registry record
    NCT07332455 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Los Angeles, CA on ClinicalTrials.gov.

Lymphoma studies recruiting in Los Angeles

  1. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Study site
    Children's Hospital Los Angeles
    Registry record
    NCT04726241 · updated
  2. A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

    • Phase 1
    • Ages 0 to 18
    • All sexes
    Sponsor
    Autolus Limited
    Study site
    Children's Hospital Los Angeles
    Registry record
    NCT06173518 · updated
  3. A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Cedar Sinai Cancer Center ( Site 0119)
    Registry record
    NCT07519772 · updated
  4. TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

    • Phase 1/2
    • Up to age 1
    • All sexes
    Sponsor
    Tanja Andrea Gruber
    Study site
    Children's Hospital Los Angeles
    Registry record
    NCT05848687 · updated
  5. A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    University of California, Los Angeles (UCLA) - Medical Center
    Registry record
    NCT07226843 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Los Angeles, CA on ClinicalTrials.gov.

Ask about studies near Los Angeles

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in California

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call